Jiang Yi-ping, Wu Xiu, Li Na, Cao Liang, Ding Gang, Wang Zhen-zhong, Xiao Wei
Zhongguo Zhong Yao Za Zhi. 2015 Aug;40(15):3068-71.
The effects of Guizhi Fuling capsule and its active ingredient combination within different concentration on SPL proliferate were observed by MTT method. The ratio of CD80/86, CD3CD25 and CD3CD69 was used to evaluate cell activation effects of Guizhi Fuling capsule and its active ingredient combination by FCM. Guizhi Fuling capsule with concentration of 400 mg · L(-1)can promote spleen lymphocyte proliferation, as well as the active ingredient combination, which showed the obvious dose-effect relationship. Compared with control group, the difference has statistical significance (P≤0.01). The result of FCM showed that Guizhi Fuling capsule and its active ingredient combination can promote CD80 and CD86 expression on spleen lymphocyte, and also can increase CD25 and CD69 ratio between spleen CD3+ cells. Compared with control group, the difference has statistical significance (P≤0.01). Thus, Guizhi Fuling capsule and its active ingredient combination may have immune-modulate effects, and the mechanism may have a close relationship with the lymphocyte activation.
采用MTT法观察不同浓度的桂枝茯苓胶囊及其有效成分组合对脾淋巴细胞增殖的影响。采用流式细胞术(FCM)检测桂枝茯苓胶囊及其有效成分组合对细胞活化的影响,以CD80/86、CD3CD25及CD3CD69的比值进行评价。浓度为400mg·L(-1)的桂枝茯苓胶囊及其有效成分组合均能促进脾淋巴细胞增殖,呈明显的剂量效应关系,与对照组比较,差异有统计学意义(P≤0.01)。FCM结果显示,桂枝茯苓胶囊及其有效成分组合均能促进脾淋巴细胞表面CD80及CD86的表达,同时可提高脾CD3+细胞中CD25及CD69的比值,与对照组比较,差异有统计学意义(P≤0.01)。因此,桂枝茯苓胶囊及其有效成分组合可能具有免疫调节作用,其机制可能与淋巴细胞活化密切相关。